Skip to main content

Table 1 Primary and secondary outcome assessments and time points for MINDS

From: The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial

Assessment tools

Baseline

3-month

6-month

12-month

Primary outcomes

 AQoL-6D (20 items)

X

X

X

X

 GSE (10 items)

X

X

X

X

Secondary outcomes

 DQoL (15 items)

X

X

X

X

 ASSIST (6 items)

X

X

X

X

 Brief COPE (28 items)

X

X

X

X

 CEQ (6 items)

X

   

 Clinical Indices (e.g. BMI)

X

X

X

X

 DES (8 items)

X

X

X

X

 EQ-5D-3L (6 items)

X

X

X

X

 HADS (14 items)

X

X

X

X

 HCUQ (17 items)

X

X

X

X

 PAID (20 items)

X

X

X

X

 TEI-SF (9 Items)

 

X

  

 BFI-10 (10 items)

X

   

 WSAS (5 items)

X

X

X

X

  1. AQoL-6D Assessment of Quality of Life-6 Dimensions [26], GSE General Self-efficacy Scale [34], DQoL Diabetes Quality of Life [35], ASSIT Alcohol, Smoking and Substance Involvement Screening Test [36], Brief COPE abbreviated version of the COPE Inventory [38], CEQ Credibility/Expectancy Questionnaire [39], BMI body mass index, DES Diabetes Empowerment Scale [40], EQ-5D-3L European Quality of Life-5 Dimensions-3 Levels [27], HADS Hospital Anxiety and Depression Scale [41], HCUQ Health Care Utilisation Questionnaire [33], PAID Problem Areas in Diabetes Scale [42], TEI-SF Treatment Evaluation Inventory-Short Form [43], BFI-10 Big Five Inventory-10 item [44], WSAS Work and Social Adjustment Scale [45]